Screener
Myriad Genetics MYGN Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Revenue | $200.4 | $195.9 |
| Cost of revenue | 62.8 | 61.7 |
| Gross profit | 137.6 | 134.2 |
| Costs and expenses: | ||
| Research and development expense | 27.1 | 27.5 |
| Sales and marketing expense | 73.6 | 69.2 |
| General and administrative expense | 62.2 | 66.5 |
| Goodwill and long-lived asset impairment charges | 5.4 | — |
Item 1. Financial Statements.
FAQ
- What is Myriad Genetics's gross profit?
- Myriad Genetics (MYGN) reported gross profit of $137.6M in Q1 2026.
- How has Myriad Genetics's gross profit changed year-over-year?
- Myriad Genetics's gross profit increased by 2.5% year-over-year, from $134.2M to $137.6M.
- What is the long-term trend for Myriad Genetics's gross profit?
- Over 3 years (2022 to 2025), Myriad Genetics's gross profit has grown at a 6.6% compound annual growth rate (CAGR), from $476.4M to $576.6M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Myriad Genetics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude